| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5497944 | BOEHRINGER INGELHEIM | Atomising devices and methods |
Mar, 2013
(11 years ago) | |
| US5472143 | BOEHRINGER INGELHEIM | Atomising nozzle and filter and spray generation device |
Sep, 2013
(10 years ago) | |
| US6007676 | BOEHRINGER INGELHEIM | Atomizing nozzle and filter and spray generating device |
Sep, 2013
(10 years ago) | |
| US6503362 | BOEHRINGER INGELHEIM | Atomizing nozzle an filter and spray generating device |
Sep, 2013
(10 years ago) | |
| US5911851 | BOEHRINGER INGELHEIM | Atomizing nozzle and filter and spray generating device |
Sep, 2013
(10 years ago) | |
| US5662271 | BOEHRINGER INGELHEIM | Atomizing devices and methods |
Sep, 2014
(9 years ago) | |
| US7246615 | BOEHRINGER INGELHEIM | Atomising nozzle and filter and spray generating device |
May, 2016
(7 years ago) | |
| US6726124 | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Oct, 2016
(7 years ago) | |
| US5964416 | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Oct, 2016
(7 years ago) | |
| US6176442 | BOEHRINGER INGELHEIM | Device for mounting a component exposed to a pressurized fluid |
Oct, 2016
(7 years ago) | |
| US7104470 | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Oct, 2016
(7 years ago) | |
| US6453795 | BOEHRINGER INGELHEIM | Locking mechanism for a spring-actuated device |
Dec, 2016
(7 years ago) | |
| US6149054 | BOEHRINGER INGELHEIM | Mechanical counter for a metering apparatus |
Dec, 2016
(7 years ago) | |
| US6977042 | BOEHRINGER INGELHEIM | Microstructured filter |
Aug, 2018
(5 years ago) | |
| US6846413 | BOEHRINGER INGELHEIM | Microstructured filter |
Aug, 2018
(5 years ago) | |
| US7802568 | BOEHRINGER INGELHEIM | Cartridge for a liquid |
Feb, 2019
(5 years ago) | |
| US6988496 | BOEHRINGER INGELHEIM | Cartridge for a liquid |
Feb, 2020
(4 years ago) | |
| US7988001 | BOEHRINGER INGELHEIM | Container provided with a pressure equalization opening |
Aug, 2021
(2 years ago) | |
| US7284474 | BOEHRINGER INGELHEIM | Piston-pumping system having o-ring seal properties |
Aug, 2024
(4 months from now) | |
| US7896264 | BOEHRINGER INGELHEIM | Microstructured high pressure nozzle with built-in filter function |
May, 2025
(1 year, 1 month from now) | |
| US7396341 | BOEHRINGER INGELHEIM | Blocking device for a locking stressing mechanism having a spring-actuated output drive device |
Oct, 2026
(2 years from now) | |
| US9027967 | BOEHRINGER INGELHEIM | Device for clamping a fluidic component |
Mar, 2027
(2 years from now) | |
| US7837235 | BOEHRINGER INGELHEIM | Device for clamping a fluidic component |
Mar, 2028
(3 years from now) | |
| US8733341 | BOEHRINGER INGELHEIM | Atomizer and method of atomizing fluid with a nozzle rinsing mechanism |
Oct, 2030
(6 years from now) | |
Combivent Respimat is owned by Boehringer Ingelheim.
Combivent Respimat contains Albuterol Sulfate; Ipratropium Bromide.
Combivent Respimat has a total of 24 drug patents out of which 18 drug patents have expired.
Expired drug patents of Combivent Respimat are:
- US5497944
- US5472143
- US6007676
- US6503362
- US5911851
- US5662271
- US7246615
- US6726124
- US5964416
- US6176442
- US7104470
- US6453795
- US6149054
- US6977042
- US6846413
- US7802568
- US6988496
- US7988001
Combivent Respimat was authorised for market use on 07 October, 2011.
Combivent Respimat is available in spray, metered;inhalation dosage forms.
The generics of Combivent Respimat are possible to be released after 16 October, 2030.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Oct 07, 2014 |
Drugs and Companies using ALBUTEROL SULFATE; IPRATROPIUM BROMIDE ingredient
Market Authorisation Date: 07 October, 2011
Treatment: NA
Dosage: SPRAY, METERED;INHALATION
COMBIVENT RESPIMAT family patents
